CAR T Global Consultant Inc.
Mike DeRidder is an accomplished professional in the biopharmaceutical industry with extensive experience in commercialization and strategic leadership roles. As a Partner at CAR T Global Consultant Inc. since February 2024, Mike previously served as SVP of Corporate Strategy and New Product Planning at Catamaran Bio, where responsibilities included leading business development and overseeing corporate communications. During a decade at GSK, Mike played a pivotal role in expanding the oncology division, led commercial diligence for major acquisitions, and developed successful strategies for various oncology cell therapy programs. Additionally, Mike has a background in consulting with L.E.K. Consulting, where numerous corporate and product strategy engagements were managed. Mike holds a PhD in Bioengineering from the University of Pennsylvania and a BSE in Biomedical Engineering from Tulane University.
This person is not in any teams
This person is not in any offices
CAR T Global Consultant Inc.
Cell and Gene therapies are unique, requiring a specific expertise. CAR T Global Consultant is a firm that specializes in the commercialization of cell and gene therapy assets. Whether your company has assets in phase 1 or have approved cell therapy products, we have the expertise to support your company aspirations.